Intended for healthcare professionals

CCBY Open access

Rapid response to:

Research

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n579 (Published 10 March 2021) Cite this as: BMJ 2021;372:n579

Read our latest coverage of the coronavirus outbreak

Linked Editorial

Covid-19: variants and vaccination

Linked Opinion

Increased risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1

Rapid Response:

Soberana 02, the first Latin American vaccine to advance to phase III.

Dear Editor
The Cuban drug becomes the first Latin American project in the fight against COVID-19 to reach that stage. The Center for the State Control of Medicines, Equipment and Medical Devices (Cecmed), authorized the start of phase III of the clinical trials of the vaccine candidate Soberana 02, after a rigorous analysis of the documentation presented by the Finlay Vaccine Institute. Very soon the mass vaccination of Soberana 02 and Abdala will begin in Havana, Santiago de Cuba and Guantánamo; and also phase II of Soberana 01 in Cienfuegos.
Cuba, shortly, will embrace a new epic, perhaps the most outstanding that can be fought today: the immunization of its people against a deadly virus that has terrorized the world. The pandemic is one of the main challenges of this time, along with global warming and the danger of a nuclear explosion. After producing - thanks to the development of biotechnology - what constitutes the first vaccine in Latin America against the SARS-COV-2 virus, according to the Pan American Health Organization and the United Nations Organization for Industrial Development, the Island will be in the ideal possibility of starting a vaccination campaign this month that will prevent its population against COVID-19.
After announcing the realization of the first batch of 150,000 doses of Soberana 02 (of the one hundred million planned) and the preparation of the second being underway, it was announced that production of the vaccine candidate Abdala also began.
Everything is happening in this country in the midst of an atrocious blockade of any financial entry by the United States into our country, is something only credible because it is about Cuba, its Revolution, its insomniac ward to preserve the health of the people.

Competing interests: No competing interests

12 March 2021
Adriana Albert Montero
Doctor
M.Sc Ihosvany Castellanos Santos, Dr. Elena Batista Ortega, Dr. Ramon F. Duarte Chaviano, Dr. Mercedes Maria Lopez Rodriguez, Lic. Olga Lidia Zerquera Calderon, Lic. Ana ivis Muñoz Alcuria, Dr. Odalys Rodriguez Guillen, Dr. María Eugenia Bravo Rodríguez, Lic Marelys Medina Barroso
MINSAP
Francisco Javier Zerquera 15. Trinidad. Cuba.